Capreomycin iia
- Level
- Commodity
- Parent
- 51281600
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51281641This classification denotes an antitubercular agent and aminoglycoside antibiotic with the molecular formula C19H32N12O7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 38TL5Q9SM7, chemically known as cyclo(3-amino-l-alanyl-(2z)-3-((aminocarbonyl)amino)-2,3-didehydroalanyl-(2s)-2-((4r)-2-amino-3,4,5,6-tetrahydro-4-pyrimidinyl)glycyl-(2s)-2-amino-.beta.-alanyl-l-seryl), but more generally known as capreomycin iia, which bears US NIH Compound Identifier 3034236. European Medicines Agency schedules capreomycin iia or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01028MIG. Most nations, for tariff purposes, schedule capreomycin iia under HS 29419000. SMILES: C1CN=C(N[C@H]1[C@H]2C(=O)NC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N/C(=C\NC(=O)N)/C(=O)N2)CN)CO)N)N.
Same parent
Under 51281600 · 75Activities that produce or sell this
KBLI · 9Inherited from family 51280000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.